Volume 22, Issue 134 (8-2015)                   RJMS 2015, 22(134): 91-100 | Back to browse issues page

XML Persian Abstract Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

In vitro Inhibitory Effect of Recombinant Human Calprotectin on K562 Cell Line. RJMS 2015; 22 (134) :91-100
URL: http://rjms.iums.ac.ir/article-1-3927-en.html
Abstract:   (3729 Views)

Background: Recombinant human Calprotectin is a protein that has inhibitory effect on the growth of cancer. This substance could use as a marker or therapeutic agents for cancer. The goal of this study was to evaluate the anti-tumor property of recombinant human Calprotectin on K562 cell line.

Methods: Recombinant human Calprotectin was cloned and purified in E. coli. Then, different concentrations (1, 5, 10, 20, 40, 80 and 100 µg/ml) were prepared in Roswell Park Memorial Institute (RPMI) and its antitumor property against K562 was assayed by MTT method at the presence of Doxorubicin as positive standard.

Results: Results showed recombinant human Calprotectin has antitumor property against K562 cell line in a concentration and time dependent manner. Statistical analysis revealed recombinant human Calprotectin significantly (P= 0.0231) has inhibitory effect on the growth on K562.

Conclusion: Based on this finding we conclude that recombinant human Calprotectin has anti-cancer properties, but its application needs further studies.

Full-Text [PDF 1490 kb]   (2948 Downloads)    
Type of Study: Research | Subject: Biology

Add your comments about this article : Your username or Email:

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2023 CC BY-NC 4.0 | Razi Journal of Medical Sciences

Designed & Developed by : Yektaweb